RZLT Rezolute, Inc.
$4.22▲ +2.68%
Healthcare
Other
After hours
$4.18▼ -0.86%
Oct 28, 4:46 PM ET
Volume 1.41M
Avg Volume (10D) 1.46M
Key Metrics & Fundamentals
Market Cap
$408.17M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.07 - 11.46
% vs 50 MA
-1.40%
% vs 200 MA
8.93%
RSI-14
53.2
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.05
Free Cash Flow
-$13.15M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$21.55M
COGS
–
Operating Exp
$21.56M
Operating Income
-$21.56M
EBIT
-$21.56M
Pretax Income
-$20.49M
Net Income
-$20.49M
EPS (Diluted)
-0.20
Price & Volume History
Loading chart…
Recent News
Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
GlobeNewswire · Oct 14, 2026 4:05 PM ET
Cantor Fitzgerald Upgrades Rezolute to Overweight From Neutral
MT Newswires · Oct 6, 2026 5:28 AM ET
Rezolute Gets FDA Nod For Pre-BLA Meeting Despite Phase 3 Miss — Retail Expects ‘Huge Rerating’
Stocktwits · Oct 5, 2026 8:58 AM ET
Rezolute Says FDA Recommends Pre-BLA Meeting for Congenital Hyperinsulinism Treatment
MT Newswires · Oct 5, 2026 8:04 AM ET
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
GlobeNewswire · Oct 5, 2026 7:00 AM ET
Craig-Hallum Upgrades Rezolute to Buy From Hold, Price Target is $7
MT Newswires · Sep 29, 2026 7:13 AM ET
Rezolute Fiscal Q4 Loss Narrows
MT Newswires · Sep 24, 2026 4:18 PM ET
Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update
GlobeNewswire · Sep 24, 2026 4:05 PM ET
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Sep 9, 2026 3:49 PM ET
Sector Update: Healthcare Stocks Decline in Afternoon Trading
MT Newswires · Sep 9, 2026 1:34 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RZLT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.